Small cell lung cancer survival: 3 Years as a minimum for predicting a favorable outcome

Lung Cancer

Volumn 40, Issue 2, 2003, Pages 203-213

  Lewiński, Tadeusz ^a   Zuławski, Maciej ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Combined modality treatment; Death hazard; Life long follow up; Long term survival; Relapse; Second primary lung cancer; Small cell lung cancer; Thorough staging

Indexed keywords

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EXPOSURE; EVALUATION; FEMALE; FOLLOW UP; HUMAN; INSTITUTIONAL CARE; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SECOND CANCER; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR;

EID: 0037405463     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(03)00025-4     Document Type: Article

References (17)

1. Matthews M.J., Rozencweig M., Staquet M.J., et al. Long-term survivors with small cell carcinoma of the lung. Eur. J. Cancer. 16:1980;527-531.
2. Lewinski T., Żuławski M., Turski C., Pietraszek A. Small cell lung cancer I-III A; cytoreductive chemotherapy followed by resection with continuation of chemotherapy. Eur. J. Cardio-Thorac. Surg. 20:2001;391-398.
3. Stephens R.J., Bailey A.J., Machin D. Long-term survival in small cell lung cancer. The case for a standard definition. Lung Cancer. 15:1996;297-309.
4. Kristjansen P.E.G., Hansen H.H. Management of small cell lung cancer. A summary of the Third International Association for the Study of Lung Cancer Workshop on Small Cell Lung Cancer. J. Natl. Cancer Inst. 82:1990;263-266.
5. Albain K.S., Crowley J.J., LeBlanc M., Livingston R.B. Determinants of improved outcome in small-cell lung cancer. An analysis of the 2580-patients Southwest Oncology Group Data Base. J. Clin. Oncol. 8:1990;1563-1574.
6. Chauvin F., Trillet V., Court-Fortune I., et al. Pretreatment staging evaluation in small cell lung carcinoma. A new approach to medical decision making. Chest. 102:1992;497-502.
7. Adjel A.A., Marks R.S., Bonner J.A. Current guidelines for the management of small cell lung cancer. Mayo Clin. Proc. 74:1999;809-816.
8. Argiris A., Murren J.R. Staging and clinical prognostic factors for small-cell lung cancer. Cancer J. 7:2001;437-447.
9. Suhami R.L., Law K. Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research. Br. J. Cancer. 61:1990;584-589.
10. Van der Gaast A., Postmus P.E., Burghouts J., et al. Long term survival of small cell lung cancer patients after chemotherapy. Br. J. Cancer. 67:1993;822-824.
11. Osterlind K., Hansen H.H., Hansen M., Dombernowsky P. Mortality and morbidity in long-term surviving patients treated with chemotherapy with or without irradiation for small-cell lung cancer. J. Clin. Oncol. 4:1986;1044-1052.
12. Armstrong J.G. Long-term outcome of small cell lung cancer. Cancer Treat. Rev. 17:1990;1-13.
13. Belani C.P., Whitacre M., Aisner J. Redefinition of outcome of long-term survivors with small cell lung cancer (SCLC). Proc. Am. Soc. Clin. Oncol. 13:1994;329. abstract 1088.
14. Johnson B.E., Ihde D.C., Bunn P.A., et al. Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a 5-11-year follow-up. Ann. Int. Med. 103:1985;430-438.
15. Johnson B.E., Grayson J., Makuch R.W., et al. Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. J. Clin. Oncol. 8:1990;396-401.
16. Vogelsang G.B., Abeloff M.D., Ettinger D.S., et al. Long-term survivors of small-cell carcinoma of the lung. Am. J. Med. 79:1985;49-56.
17. Lassen U., Osterlind K., Hansen M., et al. Long-term survival in small-cell lung cancer. Posttreatment characteristics in patients surviving 5-18+ years - an analysis of 1714 consecutive patients. J. Clin. Oncol. 13:1995;1215-1220.